Naseema Gangat, M.B.B.S.

The Gastrointestinal (GI) Cancer Program at Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota, offers hope through our expert teams of specialized doctors who provide accurate diagnoses and offer the latest treatment options for esophageal cancer, stomach cancer, colorectal cancer, anal cancer and gastrointestinal cancers that have metastasized. You will have access to the full range of cancer treatments, including minimally invasive surgeries, robotic and laparoscopic, endoscopic mucosal resection, esophagectomy, complex esophageal reconstruction, gastrectomy, hyperthermic intraperitoneal chemotherapy (HIPEC), targeted radiation treatments such as proton beam therapy, immunotherapies and cutting-edge clinical trials. Mayo Clinic’s Gastrointestinal Neoplasia Clinic specializes in the prevention, early detection, diagnostic evaluation and integrated management of luminal gastrointestinal pre-cancers and cancers for people at higher-than-average risk of stomach and colorectal cancer based on family history, personal history or having other gastrointestinal diseases like Crohn’s or ulcerative colitis. Mayo Clinic is top-ranked in more specialties than any other hospital, according to U.S. News & World Report, and the Cancer Center continually ranks among the top hospitals in the U.S. for cancer. Mayo Clinic Comprehensive Cancer Center is a National Cancer Institute (NCI)-designated comprehensive cancer center.

Mayo Clinic is a world-renowned healthcare institution, recognized as the No. 1 hospital globally, providing patient-centered medical care and a comprehensive approach to diagnosing and treating complex health issues. With locations in Arizona, Florida, and Minnesota, as well as international services, Mayo Clinic caters to patients from all around the world, ensuring access to top-ranked specialties and innovative treatments. In addition to clinical care, Mayo Clinic is dedicated to cutting-edge research and education through its various programs, including the Mayo Clinic College of Medicine and Science, which trains future healthcare professionals. By fostering groundbreaking medical research and promoting continued learning, Mayo Clinic remains at the forefront of advancements in medicine, significantly impacting patient lives and health outcomes. Generated from the website

Dr. Rahma Warsame is an associate professor of medicine and oncology at the Mayo Clinic College of Medicine and Science, specializing in hematology with a focus on plasma cell disorders, particularly amyloidosis. With over 60 peer-reviewed publications and numerous awards, she is dedicated to advancing patient care through research and education. In addition to her clinical practice, Dr. Warsame actively mentors medical students, residents, and fellows, serving as the associate program director of the internal medicine residency program. Her research interests include patient-reported outcomes, quality of life, and healthcare costs, reflecting her commitment to improving patient experiences in the field of hematology. Generated from the website